GSK Annual Report 2002

Financial record GlaxoSmithKline 143
9 months 2002 Q3 2002 6 months 2002 Q2 2002 Q1 2002
£m CER % £m CER % £m CER % £m CER % £m CER %
13,196 4,222 8,974 4,613 4,361
2,348 797 1,551 802 749
15,544 5,019 10,525 5,415 5,110
(3,356) (1,129) (2,227) (1,110) (1,117)
(5,857) (1,913) (3,944) (2,057) (1,887)
(1,995) (706) (1,289) (623) (666)
(11,208) (3,748) (7,460) (3,790) (3,670)
4,011 1,143 2,868 1,512 1,356
325 128 197 113 84
4,336 1,271 3,065 1,625 1,440
(134) (145) 11 16 (5)
4,202 1,126 3,076 1,641 1,435
58 20 38 21 17
6 6 – – –
12 – 12 – 12
4,278 1,152 3,126 1,662 1,464
(105) (42) (63) (29) (34)
4,173 1,110 3,063 1,633 1,430
(1,099) (289) (810) (430) (380)
3,074 821 2,253 1,203 1,050
(79) (31) (48) (24) (24)
(15) (5) (10) (5) (5)
2,980 785 2,195 1,174 1,021
50.2p 13.4p 36.8p 19.7p 17.1p
13,196 9 4,222 6 8,974 10 4,613 9 4,361 10
2,348 2 797 4 1,551 1 802 3 749 (1)
15,544 7 5,019 6 10,525 8 5,415 8 5,110 8
(3,168) 2 (1,041) 1 (2,127) 3 (1,052) – (1,075) 7
(5,502) 2 (1,782) 2 (3,720) 3 (1,950) 5 (1,770) –
(1,885) 4 (641) 3 (1,244) 4 (594) (3) (650) 11
(10,555) (3,464) (7,091) (3,596) (3,495)
4,628 21 1,410 18 3,218 22 1,697 23 1,521 20
361 6 145 8 216 4 122 6 94 2
4,989 19 1,555 17 3,434 21 1,819 22 1,615 19
(134) (145) 11 16 (5)
4,855 15 1,410 13 3,445 17 1,835 17 1,610 16
58 20 38 21 17
4,913 1,430 3,483 1,856 1,627
(105) (42) (63) (29) (34)
4,808 12 1,388 12 3,420 13 1,827 10 1,593 16
(1,298) (375) (923) (493) (430)
3,510 12 1,013 11 2,497 12 1,334 10 1,163 15
(79) (31) (48) (24) (24)
(15) (5) (10) (5) (5)
3,416 12 977 11 2,439 13 1,305 10 1,134 17
57.6p 15 16.7p 15 40.9p 15 21.9p 13 19.0p 18